Radiation Oncology Registry and Biosample Repository
Brief description of study
The goal of this study is to establish a registry and biosample repository (defined as blood, urine, and tumor specimens in patients with a pathologically confirmed diagnosis of neoplasia receiving radiotherapy or photodynamic therapy (PDT).
Radiation Oncology Registry (Required):
The first part of this study is the Radiation Oncology Registry. The purpose of the
registry is to collect information on individuals undergoing radiation therapy and
to use this clinical information for future research purposes.
Participation in this portion of the study requires no additional obligations on your
part; your participation means you are granting permission for your doctors to
extract information from your medical chart and use this data for research
purposes. Should any findings from this research be presented or published,
your name, date of birth, or any other personal identifying information will not be
included.
Biosample Repository:
Blood and stool collection are required for participation in this study. We will be
collecting your blood and stool at up to five different time points and storing it in
the Radiation Oncology Biosample Repository here at the University of
Pennsylvania. All samples will be collected at your normal appointment times.
These samples will be used for current or future research to study cancer. We
are hoping that research using these samples will develop better methods to
detect tumors, help patients have a better response to treatment, and reduce the
side effects of cancer treatment.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Cancer,Oncology,Tumor
-
Age: Between 18 Years - 99 Years
-
Gender: All
Updated on
09 Mar 2024.
Study ID: 851881
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting